HAZEL BREWIN: Open Payments
NPI 1376315242 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,519 in 61 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,175 · 2025 $2,519
Food & beverage: $1,983Travel & lodging: $535
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 8 | $1,015 |
| AstraZeneca Pharmaceuticals LP | 8 | $200 |
| Merck Sharp & Dohme LLC | 7 | $194 |
| E.R. Squibb & Sons, L.L.C. | 4 | $183 |
| Actelion Pharmaceuticals US, Inc. | 5 | $173 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $139 |
| ABIOMED | 1 | $123 |
| BridgeBio Pharma, Inc. | 3 | $98 |
| Medtronic, Inc. | 1 | $91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $87 |
Products named: CARDIOMEMS, WINREVAIR, CAMZYOS, OPSUMIT, FARXIGA, Attruby, Kerendia, COREVALVE EVOLUT R.
Industry payments across NC — which companies pay providers there.
